Volume 12 Supplement 1
Randomized controlled trial of the Tobacco Tactics website versus 1-800-QUIT-NOW telephone line among Operating Engineers
© Choi et al; licensee BioMed Central Ltd. 2014
Published: 6 June 2014
The purpose of this study was to evaluate the efficacy and usage of the Tobacco Tactics website compared to the 1-800-QUIT-NOW telephone line among Operating Engineers (heavy equipment operators).
Materials and methods
Smokers attending workplace safety training groups were randomized to either the Tobacco Tactics website with nurse phone counseling and access to nicotine replacement therapy (NRT) or to the 1-800-QUIT-NOW telephone line which provided an equal number of phone calls and NRT. Participating Operating Engineers completed a baseline survey as well as mailed surveys at 30-days and 6-months. Urinary cotinine tests were used to verify 6-month smoking status. The outcomes were compared using χ2 tests, t-tests, mixed models, generalized mixed models, and logistic regression models.
Compared to participants in the 1-800-QUIT-NOW group, significantly more of those in the Tobacco Tactics website group participated in the intervention, received phone calls and found the intervention helpful (p<0.05). Seventy percent of the website group received NRT compared to 5.1% of the quitline group (p<0.001). At 30-day follow-up, the Tobacco Tactics website group showed significantly higher quit rates (26.9%) than the 1-800-QUIT-NOW group (7.7%) (p<0.05), but this difference was no longer significant at 6-month follow-up. There were significantly more positive changes in harm reduction measures (quit attempts, number of cigarettes smoked per day, and nicotine dependence) at both 30-day and 6-month follow-up in the Tobacco Tactics website group compared to the 1-800-QUIT-NOW group (p<0.05).
The Tobacco Tactics website showed higher efficacy and reach than the 1-800-QUIT-NOW intervention. Longer counseling sessions may be needed to improve 6-month cessation rates. This intervention has the potential to reduce morbidity and mortality among Operating Engineers.
This work was supported by the Blue Cross Blue Shield of Michigan Foundation (BCBSM) Grant Number N011646-1465.RFP and the National Institutes of Health (NIH) Grant Number 5R21CA152247-02.
This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.